[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Covid-19 Impact on Global Advanced Cell Therapies Market Size, Status and Forecast 2020-2026

July 2020 | 90 pages | ID: C9B065116ECEEN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report focuses on the global Advanced Cell Therapies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Advanced Cell Therapies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
  • FRC Blood Service
  • Fujifilm
  • Vericel
  • Advanced Cell Technology, Inc
  • Locate Bio Limited
  • Kolon TissueGene
  • Gamida Cell
  • Okyanos
  • Rexgenero
  • BioXcellerator
  • Takura
  • Autolus
Market segment by Type, the product can be split into
  • Stem Cell Transplants
  • CAR T-cell Therapy
Market segment by Application, split into
  • Stem Cell
  • Regenerative Medicine
Market segment by Regions/Countries, this report covers
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America
The study objectives of this report are:
  • To analyze global Advanced Cell Therapies status, future forecast, growth opportunity, key market and key players.
  • To present the Advanced Cell Therapies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Advanced Cell Therapies are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Advanced Cell Therapies Revenue
1.4 Covid-19 Implications on Market by Type
  1.4.1 Global Advanced Cell Therapies Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Stem Cell Transplants
  1.4.3 CAR T-cell Therapy
1.5 Covid-19 Implications on Market by Application
  1.5.1 Global Advanced Cell Therapies Market Share by Application: 2020 VS 2026
  1.5.2 Stem Cell
  1.5.3 Regenerative Medicine
1.6 Coronavirus Disease 2019 (Covid-19): Advanced Cell Therapies Industry Impact
  1.6.1 How the Covid-19 is Affecting the Advanced Cell Therapies Industry
    1.6.1.1 Advanced Cell Therapies Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Advanced Cell Therapies Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Advanced Cell Therapies Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Covid-19 Implications on Global Advanced Cell Therapies Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Advanced Cell Therapies Growth Trends by Regions
  2.2.1 Advanced Cell Therapies Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Advanced Cell Therapies Historic Market Share by Regions (2015-2020)
  2.2.3 Advanced Cell Therapies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Advanced Cell Therapies Market Growth Strategy
  2.3.6 Primary Interviews with Key Advanced Cell Therapies Players (Opinion Leaders)

3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Advanced Cell Therapies Players by Market Size
  3.1.1 Global Top Advanced Cell Therapies Players by Revenue (2015-2020)
  3.1.2 Global Advanced Cell Therapies Revenue Market Share by Players (2015-2020)
  3.1.3 Global Advanced Cell Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Advanced Cell Therapies Market Concentration Ratio
  3.2.1 Global Advanced Cell Therapies Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Advanced Cell Therapies Revenue in 2019
3.3 Advanced Cell Therapies Key Players Head office and Area Served
3.4 Key Players Advanced Cell Therapies Product Solution and Service
3.5 Date of Enter into Advanced Cell Therapies Market
3.6 Mergers & Acquisitions, Expansion Plans

4 COVID-19 IMPLICATIONS ON MARKET SIZE BY TYPE (2015-2026)

4.1 Global Advanced Cell Therapies Historic Market Size by Type (2015-2020)
4.2 Global Advanced Cell Therapies Forecasted Market Size by Type (2021-2026)

5 COVID-19 IMPLICATIONS ON MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Advanced Cell Therapies Market Size by Application (2015-2020)
5.2 Global Advanced Cell Therapies Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Advanced Cell Therapies Market Size (2015-2020)
6.2 Advanced Cell Therapies Key Players in North America (2019-2020)
6.3 North America Advanced Cell Therapies Market Size by Type (2015-2020)
6.4 North America Advanced Cell Therapies Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Advanced Cell Therapies Market Size (2015-2020)
7.2 Advanced Cell Therapies Key Players in Europe (2019-2020)
7.3 Europe Advanced Cell Therapies Market Size by Type (2015-2020)
7.4 Europe Advanced Cell Therapies Market Size by Application (2015-2020)

8 CHINA

8.1 China Advanced Cell Therapies Market Size (2015-2020)
8.2 Advanced Cell Therapies Key Players in China (2019-2020)
8.3 China Advanced Cell Therapies Market Size by Type (2015-2020)
8.4 China Advanced Cell Therapies Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Advanced Cell Therapies Market Size (2015-2020)
9.2 Advanced Cell Therapies Key Players in Japan (2019-2020)
9.3 Japan Advanced Cell Therapies Market Size by Type (2015-2020)
9.4 Japan Advanced Cell Therapies Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Advanced Cell Therapies Market Size (2015-2020)
10.2 Advanced Cell Therapies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Advanced Cell Therapies Market Size by Type (2015-2020)
10.4 Southeast Asia Advanced Cell Therapies Market Size by Application (2015-2020)

11 INDIA

11.1 India Advanced Cell Therapies Market Size (2015-2020)
11.2 Advanced Cell Therapies Key Players in India (2019-2020)
11.3 India Advanced Cell Therapies Market Size by Type (2015-2020)
11.4 India Advanced Cell Therapies Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Advanced Cell Therapies Market Size (2015-2020)
12.2 Advanced Cell Therapies Key Players in Central & South America (2019-2020)
12.3 Central & South America Advanced Cell Therapies Market Size by Type (2015-2020)
12.4 Central & South America Advanced Cell Therapies Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 FRC Blood Service
  13.1.1 FRC Blood Service Company Details
  13.1.2 FRC Blood Service Business Overview and Its Total Revenue
  13.1.3 FRC Blood Service Advanced Cell Therapies Introduction
  13.1.4 FRC Blood Service Revenue in Advanced Cell Therapies Business (2015-2020))
  13.1.5 FRC Blood Service Recent Development
13.2 Fujifilm
  13.2.1 Fujifilm Company Details
  13.2.2 Fujifilm Business Overview and Its Total Revenue
  13.2.3 Fujifilm Advanced Cell Therapies Introduction
  13.2.4 Fujifilm Revenue in Advanced Cell Therapies Business (2015-2020)
  13.2.5 Fujifilm Recent Development
13.3 Vericel
  13.3.1 Vericel Company Details
  13.3.2 Vericel Business Overview and Its Total Revenue
  13.3.3 Vericel Advanced Cell Therapies Introduction
  13.3.4 Vericel Revenue in Advanced Cell Therapies Business (2015-2020)
  13.3.5 Vericel Recent Development
13.4 Advanced Cell Technology, Inc
  13.4.1 Advanced Cell Technology, Inc Company Details
  13.4.2 Advanced Cell Technology, Inc Business Overview and Its Total Revenue
  13.4.3 Advanced Cell Technology, Inc Advanced Cell Therapies Introduction
  13.4.4 Advanced Cell Technology, Inc Revenue in Advanced Cell Therapies Business (2015-2020)
  13.4.5 Advanced Cell Technology, Inc Recent Development
13.5 Locate Bio Limited
  13.5.1 Locate Bio Limited Company Details
  13.5.2 Locate Bio Limited Business Overview and Its Total Revenue
  13.5.3 Locate Bio Limited Advanced Cell Therapies Introduction
  13.5.4 Locate Bio Limited Revenue in Advanced Cell Therapies Business (2015-2020)
  13.5.5 Locate Bio Limited Recent Development
13.6 Kolon TissueGene
  13.6.1 Kolon TissueGene Company Details
  13.6.2 Kolon TissueGene Business Overview and Its Total Revenue
  13.6.3 Kolon TissueGene Advanced Cell Therapies Introduction
  13.6.4 Kolon TissueGene Revenue in Advanced Cell Therapies Business (2015-2020)
  13.6.5 Kolon TissueGene Recent Development
13.7 Gamida Cell
  13.7.1 Gamida Cell Company Details
  13.7.2 Gamida Cell Business Overview and Its Total Revenue
  13.7.3 Gamida Cell Advanced Cell Therapies Introduction
  13.7.4 Gamida Cell Revenue in Advanced Cell Therapies Business (2015-2020)
  13.7.5 Gamida Cell Recent Development
13.8 Okyanos
  13.8.1 Okyanos Company Details
  13.8.2 Okyanos Business Overview and Its Total Revenue
  13.8.3 Okyanos Advanced Cell Therapies Introduction
  13.8.4 Okyanos Revenue in Advanced Cell Therapies Business (2015-2020)
  13.8.5 Okyanos Recent Development
13.9 Rexgenero
  13.9.1 Rexgenero Company Details
  13.9.2 Rexgenero Business Overview and Its Total Revenue
  13.9.3 Rexgenero Advanced Cell Therapies Introduction
  13.9.4 Rexgenero Revenue in Advanced Cell Therapies Business (2015-2020)
  13.9.5 Rexgenero Recent Development
13.10 BioXcellerator
  13.10.1 BioXcellerator Company Details
  13.10.2 BioXcellerator Business Overview and Its Total Revenue
  13.10.3 BioXcellerator Advanced Cell Therapies Introduction
  13.10.4 BioXcellerator Revenue in Advanced Cell Therapies Business (2015-2020)
  13.10.5 BioXcellerator Recent Development
13.11 Takura
  10.11.1 Takura Company Details
  10.11.2 Takura Business Overview and Its Total Revenue
  10.11.3 Takura Advanced Cell Therapies Introduction
  10.11.4 Takura Revenue in Advanced Cell Therapies Business (2015-2020)
  10.11.5 Takura Recent Development
13.12 Autolus
  10.12.1 Autolus Company Details
  10.12.2 Autolus Business Overview and Its Total Revenue
  10.12.3 Autolus Advanced Cell Therapies Introduction
  10.12.4 Autolus Revenue in Advanced Cell Therapies Business (2015-2020)
  10.12.5 Autolus Recent Development

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES

Table 1. Advanced Cell Therapies Key Market Segments
Table 2. Key Players Covered: Ranking by Advanced Cell Therapies Revenue
Table 3. Ranking of Global Top Advanced Cell Therapies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Advanced Cell Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Stem Cell Transplants
Table 6. Key Players of CAR T-cell Therapy
Table 7. COVID-19 Impact Global Market: (Four Advanced Cell Therapies Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Advanced Cell Therapies Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Advanced Cell Therapies Players to Combat Covid-19 Impact
Table 12. Global Advanced Cell Therapies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Advanced Cell Therapies Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Advanced Cell Therapies Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Advanced Cell Therapies Market Share by Regions (2015-2020)
Table 16. Global Advanced Cell Therapies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Advanced Cell Therapies Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Advanced Cell Therapies Market Growth Strategy
Table 22. Main Points Interviewed from Key Advanced Cell Therapies Players
Table 23. Global Advanced Cell Therapies Revenue by Players (2015-2020) (Million US$)
Table 24. Global Advanced Cell Therapies Market Share by Players (2015-2020)
Table 25. Global Top Advanced Cell Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Advanced Cell Therapies as of 2019)
Table 26. Global Advanced Cell Therapies by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Advanced Cell Therapies Product Solution and Service
Table 29. Date of Enter into Advanced Cell Therapies Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Advanced Cell Therapies Market Size by Type (2015-2020) (Million US$)
Table 32. Global Advanced Cell Therapies Market Size Share by Type (2015-2020)
Table 33. Global Advanced Cell Therapies Revenue Market Share by Type (2021-2026)
Table 34. Global Advanced Cell Therapies Market Size Share by Application (2015-2020)
Table 35. Global Advanced Cell Therapies Market Size by Application (2015-2020) (Million US$)
Table 36. Global Advanced Cell Therapies Market Size Share by Application (2021-2026)
Table 37. North America Key Players Advanced Cell Therapies Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Advanced Cell Therapies Market Share (2019-2020)
Table 39. North America Advanced Cell Therapies Market Size by Type (2015-2020) (Million US$)
Table 40. North America Advanced Cell Therapies Market Share by Type (2015-2020)
Table 41. North America Advanced Cell Therapies Market Size by Application (2015-2020) (Million US$)
Table 42. North America Advanced Cell Therapies Market Share by Application (2015-2020)
Table 43. Europe Key Players Advanced Cell Therapies Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Advanced Cell Therapies Market Share (2019-2020)
Table 45. Europe Advanced Cell Therapies Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Advanced Cell Therapies Market Share by Type (2015-2020)
Table 47. Europe Advanced Cell Therapies Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Advanced Cell Therapies Market Share by Application (2015-2020)
Table 49. China Key Players Advanced Cell Therapies Revenue (2019-2020) (Million US$)
Table 50. China Key Players Advanced Cell Therapies Market Share (2019-2020)
Table 51. China Advanced Cell Therapies Market Size by Type (2015-2020) (Million US$)
Table 52. China Advanced Cell Therapies Market Share by Type (2015-2020)
Table 53. China Advanced Cell Therapies Market Size by Application (2015-2020) (Million US$)
Table 54. China Advanced Cell Therapies Market Share by Application (2015-2020)
Table 55. Japan Key Players Advanced Cell Therapies Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Advanced Cell Therapies Market Share (2019-2020)
Table 57. Japan Advanced Cell Therapies Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Advanced Cell Therapies Market Share by Type (2015-2020)
Table 59. Japan Advanced Cell Therapies Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Advanced Cell Therapies Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Advanced Cell Therapies Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Advanced Cell Therapies Market Share (2019-2020)
Table 63. Southeast Asia Advanced Cell Therapies Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Advanced Cell Therapies Market Share by Type (2015-2020)
Table 65. Southeast Asia Advanced Cell Therapies Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Advanced Cell Therapies Market Share by Application (2015-2020)
Table 67. India Key Players Advanced Cell Therapies Revenue (2019-2020) (Million US$)
Table 68. India Key Players Advanced Cell Therapies Market Share (2019-2020)
Table 69. India Advanced Cell Therapies Market Size by Type (2015-2020) (Million US$)
Table 70. India Advanced Cell Therapies Market Share by Type (2015-2020)
Table 71. India Advanced Cell Therapies Market Size by Application (2015-2020) (Million US$)
Table 72. India Advanced Cell Therapies Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Advanced Cell Therapies Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Advanced Cell Therapies Market Share (2019-2020)
Table 75. Central & South America Advanced Cell Therapies Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Advanced Cell Therapies Market Share by Type (2015-2020)
Table 77. Central & South America Advanced Cell Therapies Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Advanced Cell Therapies Market Share by Application (2015-2020)
Table 79. FRC Blood Service Company Details
Table 80. FRC Blood Service Business Overview
Table 81. FRC Blood Service Product
Table 82. FRC Blood Service Revenue in Advanced Cell Therapies Business (2015-2020) (Million US$)
Table 83. FRC Blood Service Recent Development
Table 84. Fujifilm Company Details
Table 85. Fujifilm Business Overview
Table 86. Fujifilm Product
Table 87. Fujifilm Revenue in Advanced Cell Therapies Business (2015-2020) (Million US$)
Table 88. Fujifilm Recent Development
Table 89. Vericel Company Details
Table 90. Vericel Business Overview
Table 91. Vericel Product
Table 92. Vericel Revenue in Advanced Cell Therapies Business (2015-2020) (Million US$)
Table 93. Vericel Recent Development
Table 94. Advanced Cell Technology, Inc Company Details
Table 95. Advanced Cell Technology, Inc Business Overview
Table 96. Advanced Cell Technology, Inc Product
Table 97. Advanced Cell Technology, Inc Revenue in Advanced Cell Therapies Business (2015-2020) (Million US$)
Table 98. Advanced Cell Technology, Inc Recent Development
Table 99. Locate Bio Limited Company Details
Table 100. Locate Bio Limited Business Overview
Table 101. Locate Bio Limited Product
Table 102. Locate Bio Limited Revenue in Advanced Cell Therapies Business (2015-2020) (Million US$)
Table 103. Locate Bio Limited Recent Development
Table 104. Kolon TissueGene Company Details
Table 105. Kolon TissueGene Business Overview
Table 106. Kolon TissueGene Product
Table 107. Kolon TissueGene Revenue in Advanced Cell Therapies Business (2015-2020) (Million US$)
Table 108. Kolon TissueGene Recent Development
Table 109. Gamida Cell Company Details
Table 110. Gamida Cell Business Overview
Table 111. Gamida Cell Product
Table 112. Gamida Cell Revenue in Advanced Cell Therapies Business (2015-2020) (Million US$)
Table 113. Gamida Cell Recent Development
Table 114. Okyanos Business Overview
Table 115. Okyanos Product
Table 116. Okyanos Company Details
Table 117. Okyanos Revenue in Advanced Cell Therapies Business (2015-2020) (Million US$)
Table 118. Okyanos Recent Development
Table 119. Rexgenero Company Details
Table 120. Rexgenero Business Overview
Table 121. Rexgenero Product
Table 122. Rexgenero Revenue in Advanced Cell Therapies Business (2015-2020) (Million US$)
Table 123. Rexgenero Recent Development
Table 124. BioXcellerator Company Details
Table 125. BioXcellerator Business Overview
Table 126. BioXcellerator Product
Table 127. BioXcellerator Revenue in Advanced Cell Therapies Business (2015-2020) (Million US$)
Table 128. BioXcellerator Recent Development
Table 129. Takura Company Details
Table 130. Takura Business Overview
Table 131. Takura Product
Table 132. Takura Revenue in Advanced Cell Therapies Business (2015-2020) (Million US$)
Table 133. Takura Recent Development
Table 134. Autolus Company Details
Table 135. Autolus Business Overview
Table 136. Autolus Product
Table 137. Autolus Revenue in Advanced Cell Therapies Business (2015-2020) (Million US$)
Table 138. Autolus Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Advanced Cell Therapies Market Share by Type: 2020 VS 2026
Figure 2. Stem Cell Transplants Features
Figure 3. CAR T-cell Therapy Features
Figure 4. Global Advanced Cell Therapies Market Share by Application: 2020 VS 2026
Figure 5. Stem Cell Case Studies
Figure 6. Regenerative Medicine Case Studies
Figure 7. Advanced Cell Therapies Report Years Considered
Figure 8. Global Advanced Cell Therapies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Advanced Cell Therapies Market Share by Regions: 2020 VS 2026
Figure 10. Global Advanced Cell Therapies Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Advanced Cell Therapies Market Share by Players in 2019
Figure 13. Global Top Advanced Cell Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Advanced Cell Therapies as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Advanced Cell Therapies Revenue in 2019
Figure 15. North America Advanced Cell Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Advanced Cell Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Advanced Cell Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Advanced Cell Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Advanced Cell Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Advanced Cell Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Advanced Cell Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. FRC Blood Service Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. FRC Blood Service Revenue Growth Rate in Advanced Cell Therapies Business (2015-2020)
Figure 24. Fujifilm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Fujifilm Revenue Growth Rate in Advanced Cell Therapies Business (2015-2020)
Figure 26. Vericel Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Vericel Revenue Growth Rate in Advanced Cell Therapies Business (2015-2020)
Figure 28. Advanced Cell Technology, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Advanced Cell Technology, Inc Revenue Growth Rate in Advanced Cell Therapies Business (2015-2020)
Figure 30. Locate Bio Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Locate Bio Limited Revenue Growth Rate in Advanced Cell Therapies Business (2015-2020)
Figure 32. Kolon TissueGene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Kolon TissueGene Revenue Growth Rate in Advanced Cell Therapies Business (2015-2020)
Figure 34. Gamida Cell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Gamida Cell Revenue Growth Rate in Advanced Cell Therapies Business (2015-2020)
Figure 36. Okyanos Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Okyanos Revenue Growth Rate in Advanced Cell Therapies Business (2015-2020)
Figure 38. Rexgenero Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Rexgenero Revenue Growth Rate in Advanced Cell Therapies Business (2015-2020)
Figure 40. BioXcellerator Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. BioXcellerator Revenue Growth Rate in Advanced Cell Therapies Business (2015-2020)
Figure 42. Takura Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Takura Revenue Growth Rate in Advanced Cell Therapies Business (2015-2020)
Figure 44. Autolus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Autolus Revenue Growth Rate in Advanced Cell Therapies Business (2015-2020)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed


More Publications